WILLAMETTE VALLEY VINEYARDS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WILLAMETTE VALLEY VINEYARDS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.20M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $39.78M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $39.14M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $33.93M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $31.79M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $27.31M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $24.75M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $23.08M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $20.85M | Mar 21, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $20.85M | Mar 22, 2018 |
| FY2017 | Dec 31, 2016 | $19.43M | Mar 22, 2018 |
| FY2015 | Dec 31, 2015 | $5.06M | Mar 10, 2016 |
| FY2015 | Sep 30, 2015 | $4.25M | Mar 10, 2016 |
| FY2015 | Jun 30, 2015 | $4.72M | Mar 10, 2016 |
| FY2015 | Mar 31, 2015 | $3.91M | Mar 10, 2016 |
| FY2015 | Dec 31, 2014 | $4.45M | Mar 10, 2016 |
| FY2015 | Sep 30, 2014 | $4.05M | Mar 10, 2016 |
| FY2015 | Jun 30, 2014 | $3.69M | Mar 10, 2016 |
| FY2015 | Mar 31, 2014 | $2.97M | Mar 10, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.49M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $24.20M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $22.56M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $18.81M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $18.67M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $16.73M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $15.29M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $14.78M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $12.88M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $12.22M | Mar 22, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($917.7K) | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | ($117.9K) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | ($1.20M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($646.5K) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $2.45M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $3.39M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $2.51M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $2.86M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $2.99M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $2.63M | Mar 22, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.44M) | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $571.9K | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | ($1.21M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($546.4K) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $3.69M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $5.00M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $3.73M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $4.18M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $3.64M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $4.17M | Mar 22, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.49M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $6.50M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $6.20M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $5.72M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $5.37M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $4.27M | Mar 29, 2022 |
| FY2017 | Dec 31, 2017 | $9.25M | Mar 22, 2018 |
| FY2017 | Dec 31, 2016 | $8.05M | Mar 22, 2018 |
| FY2016 | Dec 31, 2015 | $7.57M | Mar 23, 2017 |
| FY2015 | Dec 31, 2014 | $6.21M | Mar 10, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.79M) | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | ($3.24M) | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | ($1.99M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($2.67M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $2.57M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $4.87M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $4.29M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $2.30M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $2.52M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $3.09M | Mar 22, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $444.2K | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.85M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $4.31M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $14.81M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $10.05M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $4.18M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $4.53M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $4.05M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $2.78M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $4.33M | Mar 22, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $107.74M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $109.02M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $105.71M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $98.68M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $91.38M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $79.49M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $67.92M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $61.48M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $59.70M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $44.87M | Mar 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $41.55M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $39.78M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $35.07M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $28.32M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $26.41M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $20.67M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $18.87M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $13.92M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $14.95M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $10.24M | Mar 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.19M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $69.23M | Mar 24, 2026 |
| FY2025 | Dec 31, 2023 | $70.64M | Mar 24, 2026 |
| FY2024 | Dec 31, 2022 | $70.36M | Mar 25, 2025 |
| FY2023 | Dec 31, 2021 | $64.96M | Mar 26, 2024 |
| FY2022 | Dec 31, 2020 | $58.82M | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | $49.05M | Mar 29, 2022 |
| FY2020 | Dec 31, 2018 | $47.56M | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | $44.74M | Mar 11, 2020 |
| FY2018 | Dec 31, 2016 | $34.63M | Mar 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.19M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $17.36M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $19.73M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $22.98M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $25.49M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $24.49M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $22.21M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $20.73M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $18.89M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $16.60M | Mar 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $410.9K | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $320.9K | Mar 24, 2026 |
| FY2025 | Dec 31, 2023 | $238.5K | Mar 24, 2026 |
| FY2024 | Dec 31, 2022 | $338.7K | Mar 25, 2025 |
| FY2023 | Dec 31, 2021 | $13.75M | Mar 26, 2024 |
| FY2022 | Dec 31, 2020 | $14.00M | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | $7.05M | Mar 29, 2022 |
| FY2020 | Dec 31, 2018 | $9.74M | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | $13.78M | Mar 11, 2020 |
| FY2018 | Dec 31, 2016 | $5.71M | Mar 21, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.02M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | $12.91M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | $6.96M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $6.45M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $4.93M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $5.39M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $6.42M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $6.84M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $7.24M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | $4.87M | Mar 22, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 25, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 28, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 11, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 22, 2018 |
| FY2015 | Dec 31, 2015 | 0 | Mar 10, 2016 |
| FY2015 | Sep 30, 2015 | 0 | Mar 10, 2016 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | 0 | Mar 22, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Mar 22, 2018 |
| FY2015 | Dec 31, 2015 | 0 | Mar 10, 2016 |
| FY2015 | Sep 30, 2015 | 0 | Mar 10, 2016 |
| FY2015 | Jun 30, 2015 | 0 | Mar 10, 2016 |
| FY2015 | Mar 31, 2015 | 0 | Mar 10, 2016 |
| FY2015 | Dec 31, 2014 | 0 | Mar 10, 2016 |
| FY2015 | Sep 30, 2014 | 0 | Mar 10, 2016 |
| FY2015 | Jun 30, 2014 | 0 | Mar 10, 2016 |
| FY2015 | Mar 31, 2014 | 0 | Mar 10, 2016 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.98M | Mar 24, 2026 |
| FY2025 | Dec 31, 2024 | 4.96M | Mar 24, 2026 |
| FY2024 | Dec 31, 2023 | 4.96M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 4.96M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 4.96M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | 4.96M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | 4.96M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | 4.96M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | 4.96M | Mar 21, 2019 |
| FY2017 | Dec 31, 2016 | 5.02M | Mar 22, 2018 |